KMTS
Kestra Medical Technologies, Ltd.
25.80$
-2.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 239.6% | 98.7% | 59.5% | 48.6% | |
| – | – | -139.6% | 1.3% | 40.5% | 51.4% | |
| – | – | 206.5% | 55.7% | 26.2% | 20.5% | |
| – | – | 250.3% | 105.2% | 192.2% | 172.5% | |
| – | – | 914.4% | 307.1% | 218.3% | 193.0% | |
| – | – | -1,054.0% | -305.8% | -177.8% | -141.6% | |
| – | – | 73.8% | 22.4% | 12.9% | 7.9% | |
| – | – | -1,103.8% | -338.3% | -190.1% | -138.0% | |
| – | – | 0.2% | 0.1% | 0.2% | 0.3% | |
| – | – | -1,104.0% | -338.4% | -190.3% | -138.4% | |
| – | – | -966.4% | -274.3% | -163.8% | -143.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.